IXICO (LON:IXI) Stock Passes Below Two Hundred Day Moving Average – Here’s What Happened

IXICO plc (LON:IXI) passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 8.71 and traded as low as GBX 8.17. IXICO shares last traded at GBX 8.17, with a volume of 66,349 shares.

IXICO Trading Down 3.0%

The company has a debt-to-equity ratio of 5.22, a quick ratio of 4.90 and a current ratio of 2.83. The stock has a market cap of £17.52 million, a P/E ratio of -4.10, a P/E/G ratio of -0.38 and a beta of 0.13. The stock has a 50-day moving average price of GBX 8.24 and a 200-day moving average price of GBX 8.68.

IXICO (LON:IXI) last announced its earnings results on Tuesday, May 19th. The company reported GBX (1.21) earnings per share for the quarter. IXICO had a negative net margin of 24.98% and a negative return on equity of 16.18%. The company had revenue of GBX 395 million during the quarter. On average, equities research analysts expect that IXICO plc will post -289.3584879 EPS for the current year.

Insider Activity

In related news, insider Mark Warne bought 50,006 shares of the business’s stock in a transaction that occurred on Wednesday, July 15th. The stock was bought at an average cost of GBX 8 per share, for a total transaction of £4,000.48. Corporate insiders own 3.05% of the company’s stock.

IXICO Company Profile

IXICO is a global leader in neuroscience imaging and biomarker analytics, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring.

By unlocking valuable insights into drug safety and efficacy, IXICO has built a global reputation and 20-year track record as an end-to-end Imaging Contract Research Organisation (iCRO) managing and analysing neurological clinical trials.